Objetivo In the Healthcare industry, digital health-care solutions will become vital in order to ensure a sustainable and efficient health system in both a time and cost effective manner. mySkin d.o.o aims to significantly contribute in creating innovative and sustainable principles in the Healthcare market, by improving the quality of life for acne sufferers and working conditions for medical professionals. mySkin proposes an innovative ICT concept for a digital skin-care service based on acne sufferers and dermatologists, applying new sets of rules, values and model to the health-care market, which ultimately disrupts the existing traditional skin care market. Up to now, acne assessment was only possible visiting dermatologist and traditional acne assessment was a time and money consuming procedure. Nowadays the progress of software solutions combined with the point of care devices can for the first time offer a better and cheaper alternative to the millions of acne sufferers and thousands of dermatologistsThe overall objective of ScanZ project is to move the system from technology readiness level 7 to 9, making the device clinically and commercially qualified for the market. The expected outcome of the project is to start the full commercialization of the ScanZ device at the end of PH2 as a medically certified IP protected user-centred designed system to be sold to hospitals. During the first medical trial at ORS Hospital Belgrade, mySkin obtained significant positive feedback from patients and medical professionals; and whilst scouting the dermatology clinics for holding medical trials during the PH2 project ScanZ has received strong interest from dermatology clinics across Europe as well as positive reviews from TechCrunch, CNET, NY Daily News, and the BBC. Ámbito científico medical and health sciencesclinical medicinedermatologymedical and health sciencesclinical medicineobstetricsmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibioticsmedical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistancenatural sciencescomputer and information sciencessoftwaresoftware applications Palabras clave digital medical device medical device acne diagnostic device point-of care devices acne sufferers imagining device health care acne assessment dermatology e-health m-health Programa(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.4. - Active ageing and self-management of health H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument H2020-EU.3.1.6. - Health care provision and integrated care Tema(s) SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well Convocatoria de propuestas H2020-SMEInst-2016-2017 Consulte otros proyectos de esta convocatoria Convocatoria de subcontratación H2020-SMEINST-2-2016-2017 Régimen de financiación SME-2 - SME instrument phase 2 Coordinador MYSKIN DOO BEOGRAD (STARI GRAD) Aportación neta de la UEn € 1 613 347,75 Dirección KOSOVSKA 17/II 11000 Belgrade Serbia Ver en el mapa Pyme Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención. Sí Región Србија - север Београдски регион Београдска област Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Enlaces Contactar con la organización Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 2 304 782,50
